Combined administration of lecozotan SR [sustained-release] and citalopram: a double blind, multiple dose study in young healthy subjects

Trial Profile

Combined administration of lecozotan SR [sustained-release] and citalopram: a double blind, multiple dose study in young healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jul 2011

At a glance

  • Drugs Citalopram; Lecozotan
  • Indications Alzheimer's disease; Depressive disorders
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 04 Jul 2011 Results published in the European Neuropsychopharmacology.
    • 20 Sep 2008 Results presented at ECTRIMS/ACTRIMS/LACTRIMS
    • 10 Dec 2007 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top